Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds eukaryotic cell or component thereof or substance...
Patent
1996-09-18
2000-08-22
Johnson, Nancy A
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds eukaryotic cell or component thereof or substance...
4241731, 4241441, 4241301, 5303871, 5303887, 53038873, 53038875, 53038885, 5303896, A61K 39395, C07K 1628
Patent
active
061068349
ABSTRACT:
A method for the prevention or reversal of transplant rejection, or for therapy for autoimmune diseases, is provided comprising administering compounds such as monoclonal antibodies, that bind specifically to one or more preselected CD45R leukocyte antigens, including the CD45RB epitope.
REFERENCES:
patent: 4626507 (1986-12-01), Trowbridge et al.
patent: 5100899 (1992-03-01), Calne
patent: 5565491 (1996-10-01), Schieven
Sewer, Gen Eng News 14:10, 1994.
Nishikawa, M., et al., "Effects of Monoclonal Antibody against CD45RB on Peripheral Blood Mononuclear Cell Proliferation and on HLA-DR and Adhesion Molecule Expression on Thyrocytes of Patients with Autoimmune Thyroid Disease", Thyroid, vol. 5, No. 4, pp. 265-272, (1995).
Ozcay, N., et al., "Prevention of heart allograft rejection by monoclonal antibody to CD45RB", Turk. J. Surg., vol. 11, No. 6, pp. 372-376, (1995) Abstract Only.
Streuli, M., et al., "Characterization of CD45 and CD45R Monoclonal Antibodies Using Transfected Mouse Cell Lines That express Individual Human Leukocyte Common Antigens", J. Immunology., vol. 141, No. 11, 3910-3914, (Dec., 1988).
R. J. Benjamin, et al., "Induction of Tolerance by Monoclonal Antibody Therapy", Nature, 320, 449-451, (1986).
C. I. Bindon, et al., "Therapeutic Potential of Monoclonal Antibodies to the Leukocyte-Common Antigen", Transplantation, 40, 538-544, (1985).
M L Birkeland, et al., "Epitopes on CD45R (T200) Molecules Define Differentiation Antigens on Murine B and T Lymphocytes", J. Mol. Cell. Immunol., 4, 71-85, (Nov., 1988).
Y. Brewer, et al., "Effect of Graft Perfusion with Two CD45 Monoclonal Antibodies on Incidence of Kidney Allograft Rejection", Lancet, 935-937, (Oct., 1989).
L. Chatenoud, et al., "Anti-CD3 Antibody Induces Long-Term Remission of Overt Autoimmunity in Nonobese Diabetic Mice", Proc. Natl Acad. Sci. USA, 91, 123-127, (Jan., 1994).
A. B. Cosimi, et al., "In Vivo Effects of Monoclonal Antibody to ICAM-1 (CD54) in Nonhuman Primates with Renal Allografts", J. Immunol., 144, 4604-4612, (1990).
J. W. Fabre, et al., "Immunosuppressive Properties of Rabbit Antibodies Against a Major Glycoprotein Restricted to Rat Leukocyte Membranes", Transplantation, 30, 167-173, (Sep., 1980).
J. W. Fabre, et al., "Quantitative Serological Analysis ofa Rabbit Anti-Rat Lymphocyte Serum and Preliminary BioChemical Characterization of the Major Antigen Recognized", Transplantation, 23, 349-359, (Apr., 1977).
J. L. Fahey, et al., "Status of Immune-Based Therapies in HIV Infection and Aids", Clin. Exp. Immunol., 88, 1-5, (Jan., 1992).
G. Hale, et al., "Pilot Study of Campath-1, a Rat Monoclonal Antibody that Fixes Human Complement, as an Immunosuppressant in Organ Transplantation", Transplantation, 42, 308-311, (Sep., 1986).
W. J. Harris, et al., "Therapeutic Antibodies--The Coming of Age", Tibtech, vol. II, Meeting Report, 42-44, (Feb., 1993).
R. Hasan, et al., "Evidence That Long-Term Survival of Concordant Xenografts is Achieved by Inhibition of Antispecies Antibody Production", Transplantation, 54, 408-413, (Sep., 1992).
C. E. Haug, et al., "A Phase I Trial of Immunosuppression With Anti-ICAM-1 (CD54) mAb in Renal Allograft Recipients", Transplantation, 55, 766-773, (Apr., 1993).
M. Isobe, et al., "Specific Acceptance of Cardiac Allograft After treatment with Antibodies to ICAM-1 and LFA-1", Science, 255, 1125-1127, (Feb., 1992).
L. K. Jolliffe, "Humanized Antibodies: Enhancing Therapeutic Utility Through Antibody Engineering", Intern. Rev. Immunol., 10, 241-250, (1993).
M. Jonker, et al., "The Influence of OKT8F Treatment on Allograft Survival in Rhesus Monkeys", Transplantation, 41, 431-435, (Apr., 1986).
R. L. Kirkman, et al., "A Randomized Prospective Trial of Anti-TAC Monoclonal Antibody in Human Renal Transplantation", Transplantation, 51, 107-113, (Jan., 1991).
R. L. Kirkman, et al., "The Effect of Anti-Interleukin-2-Receptor Monoclonal Antibody on Allograft Rejection", Transplantation, 40, 719-772, (Dec., 1985).
R. Lai, et al., "Tissue Distribution of Restricted Leukocyte Common Antigens-A Comprehensive Study with Protein-and Carbohydrate-Specific CD45R Antibodies", Laboratory Investigation, 64, See Table 2, 844-854, (Jun., 1991).
A. I. Lazarovits, et al., "A Monoclonal Antibody, 7G5 (CD7), Induces Modulation of Tp40 and Inhibits Proliferation in the Allogeneic and Autologous Mixed Lymphocyte Reactions", Transplant. Proc., 20, 1253-1257, (Dec., 1988).
A. I. Lazarovits, et al., "Human Mouse Chimeric CD7 Monoclonal Antibody (SDZCHH380) for the Prophylaxis of Kidney Transplant Rejection", J. Immunol., 150, 5163-5174, (Jun., 1993).
A. I. Lazarovits, et al., "Inhibition of Alloreactivity in Vitro by Monoclonal Antibodies Directed Against Restricted Isoforms of the Leukocyte-Common Antigen (CD45)", Transplantation, 54, 724-729, (Oct., 1992).
A. I., Lazarovits, et al., "Prevention and Reversal of Renal Allograft Rejection by Antibody Against CD45RB", Nature, 380, 717-720, (Apr., 1996).
A. I. Lazarovits, "T Lymphocyte Activation and CD45/45R Antibodies (Mab)", Tissue Antigen--Histocompatibility and Immunogenetics, 33, Abstract, 275, (Feb., 1989).
W. J. Leonard, et al., "A Monoclonal Antibody that Appears to Recognize the Receptor for Human T-Cell Growth Factor; Partial Characterization of the Receptor", Nature, 300, 267-269, (1982).
P. W. Mathieson, et al., "Monoclonal-Antibody Therapy in Systemic Vasculitis", N. Eng. J. Med., 323, 250-254, (Jul., 1990).
E. K. Nakakura, et al., "Potent And Effective Prolongation By Anti-LFA-1 Monoclonal Antibody Montherapy Of Non-Primarily Vascularized Heart Allograft Survival In Mice Without T Cell Depletion", Transplantation, 55, 412-417, (Feb., 1993).
M. R. Nicolls, et al., "Induction of Long-Term Specific Tolerance to Allografts in Rats by Therapy With an Anti-CD3-Like Monoclonal Antibody", Transplantation, 55, 459-468, (1993).
N. Ogasa, et al., "Altered Expression of Cytokine Genes by CD45RB Monoclonal Antibody in Renal Allograft Rejection", Transplantation Proceedings, 27, No. 1, 398, (Feb., 1995).
Ortho MultiCenter Transplant Study Group. "A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadeveric Transplants", N. Eng. J. Med., 313, 337-342, (Aug., 1985).
T. C. Pearson, et al., "Lymphocyte Changes Associated with Prolongation of Cardiac Allograft Survival in Adult Mice Using Anti-CD4 Monoclonal Antibody", Clin. Exp. Immunol., 92, 211-217, (1993).
T. C. Pearson, et al., "The Assessment of Transplantation Tolerance Induced by Anti-CD4 Monoclonal Antibody in the Murine Model", Transplantation, 55, 361-367, (Feb., 1993).
N. Perico, et al., "Toward Novel Antirejection Strategies: In Vivo Immunosuppressive Properties of CTLA4Ig", Kidney International, 47, 241-246, (1995).
S. Poppema, et al., "Antobody MT3 is Reactive with a Novel Exon B-Associated 190-Da Sialic Acid-Dependent Epitope of the Leukocyte Common Antigen Complex", The Journal of Immunology, 147, No. 1, 218-223, (Jul., 1991).
J. A. Powelson, et al., "CDR-Grafted OKT4A Monoclonal Antibody in Cynomolgus Renal Allograft Recipients", Transplantation, 57, 788-793, (Mar., 1994).
G. Sandberg, "Anti-Lymphocyte Serum", Encyclopedia of Immunology, Academic Press, London, Roitt, I. M., ed., 142-144, (Dec., 1992).
P. Sempe, et al., "In Vivo Treatment With Monoclonal Antibodies", Imhof, B., `Lymphatic Tissues in Vivo Immune Responses`, Dekker, New York, 649-653, (1991).
P. Sempe, et al., "Role of CD4+CD45RA+T Cells in the Development of Autoimmune.Diabetes in the Non-Obese Diabetic (NOD) Mouse", Intern Immunol., 5, 479-489, (1993).
F. W. Shen, "Monoclonal Antibodies To Mouse Lymphocyte Differentiation Alloantigens", 25-31, (1981).
I. Stamenkovic, et al., "The B Lymphocyte Adhesion Molecule CD22 Interacts with Leukocyte Common Antigen CD45RO on T Cells and alpha2-6 Sialyltransferase, CD75, on B Cells", Cell, 66, 1133-1144, (Sep., 1991).
T. A. Waldmann, "Monoclonal Antibodies in Diagnosis and Therapy", Science, 252, 1657-1662, (Jun., 1991).
H. Yakura, et al., "Alleviation of Autoimmunity in BXSB Mice by Monoclonal Alloantibody to Ly-5 (CD45)", Eur. J. Immunol., 19, 1505-1508,
Lazarovits Andrew I.
Poppema Sibrand
Johnson Nancy A
Research Corporation Technologies Inc.
LandOfFree
Use of anti-CD45 leukocyte antigen antibodies for immunomodulati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of anti-CD45 leukocyte antigen antibodies for immunomodulati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of anti-CD45 leukocyte antigen antibodies for immunomodulati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577570